Stock Watch: CSUH.OB, MHTX.OB, BIEL.PK, SPHRY.PK

TRBN: [correction]

In response to my recent post regarding Trubion Pharmaceuticals, I received an email from Amy, who works for the company, pointing out the fact that I mis-identified one of their Wyeth (WYE)-partnered drugs, TRU-015 as TRU-105. I've corrected the mistake on the original post and I ask readers to take note of the change.

My outlook for the stock has not changed, however, and it's still a decent long term pick, in my opinion. I've got it on my watch list and I may pick up a few shares if it dips below five.


CSUH.OB: On September fourth the Celsius "Hot Spot" blog, located on the company web site, reported that good news would be released the following week. That news was announced last Thursday in a blog update that stated that the company is set to launch nationwide cable television ads during the coming week.

With recent financing in place and the Celsius product growing in both awareness and popularity, the nation wide television ads could only be construed as a positive development that could potentially launch Celsius into the mainstream of America.

It's also my opinion that the big news events are just beginning. I don't think that the TV ads are the least big piece of news that CEO Steve Haley has up his sleeve. With the fall television season beginning next week, we could have more in store. Of course, that is just my own speculation.

As for the stock price, the forty five cent close on Friday could be an attractive entry point for those who have been waiting on the sidelines looking to get in; those who bought in at fifty or above may want to average down a bit, but I think that Friday's drop is a result of a 'tree shake' where stop-loss orders were taken out and shareholders who run at the first sign of trouble sold.

Regardless of the day to day price action of the stock, the company is in the early stages of a huge growth phase, in my opinion, and the nationwide advertising will only help.

A few years down the road, anyone still holding from below a dollar is going to be sitting pretty, in my opinion.

MHTX.OB: Shares of Manhattan Scientifics tripled in price over the course of the last trading week and while I can't blame some shareholders for selling into the triple, I've retained 100% of my position and will hold for the long term. If any of this company's technologies - such as their nano-structured metals - 'hits,' then price increases of a lot more than a triple will be in store for the future.

The company also announced in a press release issued on Friday that it has initiated an investor relations program with Premier Media Services, Inc. The founder and President of Premier stated that (quoting directly from the PR),

Based upon our meetings with management and review of their recent activity, we are convinced that Manhattan has the ability to recover past shareholder values.

That statement has yet to be seen, but the fact of the matter is that if Manhattan can take their super light-weight metals to market then shareholders are going to be very happy, regardless of who is running the PR firm.

I loved the risk/reward profile of MHTX at five cents, but I still think it could be worth the risk while trading in the teens. That being said, the price could drop below a dime again - where it would obviously be a better buy than it is now - because it'll take real news, a lot of speculation or some big investors coming on board at these prices in order for the recent triple to stand.

An investment in MHTX can either be an investment where you buy shares now based on the potential of the technology - in order to check back in a year or two and see what's going on, or you can trade in and out of the new found volatility in order to reduce your exposure to risk.

I'm taking the buy now and check back later approach with this one. Let's see what they can do with the technology.


BIEL.PK: It's worth keeping an eye on shares of BioElectronics right now. After consolidating in the six to eight cent trading range for weeks, the stock has renewed it's run and closed the week at over eleven cents.

Ultimately (mid to long term) I think that a buy for eleven cents is going to turn out to be a steal, but for the short term I also wouldn't be surprised to see another drop to below ten cents. That being said, I wouldn't hold my breath on this one as any decent news from the FDA regarding pending applications could send BIEL to over twenty cents, in my opinion.

I'm fully consolidated in my position with BIEL and won't be a buyer unless it hits a nickel again - something that I don't believe will happen - but ActiPatch and RecoveryRX could be huge global sellers in the future and investors should want in now.

In all honesty I'm surprised that this company traded for below a penny at one point and I'm even more surprised that Big Pharma hasn't snapped up BioElectronics and its technology.

I still call BIEL a buy - but pay attention and average down when you can. Long term, we've got a winner here - in my opinion.

SPHRY.PK: Shares of Starpharma Holdings closed the trading week at a 52-week high of $4.05. I've been patiently waiting for this one to dip to three bucks - it's come close - and I'd love to hold a few shares of SPHRY because if VivaGel performs as advertised, then Starpharma is going to be huge - in my opinion.

The product has only been tested in one human trial, so therefor more trials are needed to confirm the positive results of the first one, but the potential of the VivaGel product is huge.

Keep this one on the watch list and buy the dips - I've almost given up on a drop to $3, but I want in, so on the next significat dip I'll be looking to buy a few shares.

Disclosure: long BIEL.PK, MHTX.OB, and CSUH.OB

Comments

[Assaf Chacham:]

I had BIEL at 0.067 and out at 0.114. I was out because of the finance and the management of the company. I will be glad if you can express your opinion about the Joe Noel - why he post at yahoo boards? what about their finance (look at pinksheets.com) and the restriction from scottrade.

Many thanks.

Sep 13 08:25 AM

[mlongj:]

VCF

I took you advice on CSUH shortly after the Aug 24th article and have been accumulating ever since on any slight pullbacks (have averaged down to .486). I bought several thousand more shares on Friday and will get some more this week if I am lucky. I have gone out and bought the product and determined that this is a very unique drink indeed! It is completely natural and supplies the energy boost as advertised. It is in GNC stores and Kum and Go's locally. I also see it has been distributed nationally in every major metropolitan area. 7-11 and a slew of other grocery chains across the country have the product on hand. I can see a Wal-Mart deal in the near future! That will put it way over the top in my opinion. I also noticed that Celsius is rubbing elbows with some very familiar celebrities lately. This can only be good for the company going forward. Imagine an endorsement from a sports celeb! They are showing how to market a new product "quietly" before going public by getting all their ducks in a row. Most everyone I talk to doesn't even know about the product yet. However, those that have given it a try just love the stuff! I know it will go over really well on college campuses when the nationwide campaign hits the air. It is going to be a great investment going forward.

I must thank you for your analysis on this one as I had never heard of this company until your article. You do a great service.

By the way I have made some good money on other stocks you have recommended, such as Biomatrix and Advanced Cell Technologies and Sirius XM (which I was already invested in). I am certain that I would never have taken a chance on any of these "penny" stocks had you not outlined the reasons why they are all good investments. Celsius, however, is going to be a monster!

Thanks again!

Long CSUH.OB

Sep 13 09:55 AM

[BGW:]

VFC

I was wondering if you could comment on SPPI.

Thank You!

Sep 13 02:41 PM

[Robert0713:]

I had a few shares of BIEL.PK, but when I dug into the history, I was out. It's been a PinkSheet for a decade, sued and lost, suspended by Maryland, and prints shares like tissue paper. It's one thing to be a PK for some time at the beginning, but a decade? The company's either incompetent, or just a share mill for the benefit of "management".

Sep 13 08:15 PM

[smarttogether:]

I've owned shares in Starpharma for a couple of years now. I would not wait to pick some up, if I were you. I would establish a position now and buy more on dips. This company has some fantastic products in it's pipeline and if any one of them hit, it will take off quickly. Take a look at www.nanalyze.com/forum... for more info, or the company website: www.starpharma.com

Sep 13 08:56 PM

[J E Gage:]

Our company has purchased shares in MHTX for many years now, bought at $ .45 when MHTX first started trading, can not remember the year. Continued to buy at the $ 5.00-$7.00 level. If management will protect stockholder equity, this stock should be accumulated. We are in this investment for the long term and would be a major owner should additional capital become available.

Sep 14 01:57 AM

[Factation:]

US Patent Grant Extends VivaGel(R) Coverage to 2024

MELBOURNE, Australia, Sept 22, 2009 /PRNewswire via COMTEX/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced that it has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to protect against sexually transmitted infections (STIs).
The granting of this patent means that any product presentation of SPL7013 (the active ingredient in VivaGel(R) ) is now protected in the US for an additional five years until 2024, with a possible further 12 month extension to 2025. Given the importance of genital herpes and other STIs in the US, this market is clearly a major commercial opportunity for VivaGel(R) products.

This composition of matter patent is the third patent for VivaGel(R) to be granted in the US, and adds to the already extensive patent coverage for the product in 26 countries covering all major markets.

VivaGel(R) is being developed as a condom coating in collaboration with SSL International plc (LSE: SSL), the world's leading condom company. SSL markets the global brand Durex(R), and holds approximately 40% of the global branded condom market. Following a deal announced in 2008, SSL has exclusive marketing rights for the VivaGel(R) coated condom.

Starpharma is also developing VivaGel(R) as a vaginal microbicide to prevent the transmission of STIs, including HIV and genital herpes.

About Starpharma

Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL has two operating companies, Starpharma Pty Ltd in Melbourne, Australia and DNT, Inc in the USA.

The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes. In September 2008 Starpharma signed a full licence agreement with SSL International plc (LSE: SSL) to develop a VivaGel(R) coated condom. Starpharma's receipts under the agreement are estimated to exceed A$100m comprising royalties on SSL sales, further milestone payments, and development support.


For further information:
Media:
Buchan Consulting
Rebecca Wilson
Tel: [phone]
Mob: [phone]
[e-mail]

Ellie Papathanasiou
Tel: [phone]
[e-mail]

Starpharma:
Dr Jackie Fairley
Chief Executive Officer
[phone]

Ben Rogers
Company Secretary
[phone]
[e-mail]
starpharma.com

SOURCE Starpharma Holdings


URL: www.starpharma.com
prnewswire.com
Copyright (C) 2009 PR Newswire. All rights reserved

Sep 22 12:03 PM

[Roy Manning:]

Take a look at IVOB. They have a new invitro fertilization device thats been approved in Europe, India and South America. They are going for approval in the USA market. The device cuts the cost of invitro in half. The market cap is below $20 million so it has a great upside potential.

Sep 23 06:38 PM

[smarttogether:]

Starpharma jumped 16% today in Australia (12% in US) on the news
it's patent protection was extended. VFC I still don't think you should wait for it to go down to $3 before buying - that would be a 33% drop from where it is now.

Sep 23 08:23 PM

[smarttogether:]

Watching the Australian market tonight. Starpharma is up another 10%.

Sep 27 10:05 PM

[Michelle K.:]

VFC- I just bought BIEL at .08. I don't know that much about stocks. Do you think I made a mistake or do you think it will spike soon? I don't have alot of money to invest so the only way I saw potental for a huge gain was with BIEL. I've read alot of your articles and believe you know what your talking about. I visited Bioelectronics website and think they have a great product, especially Allay. I hope that hits the shelf soon ; ) any advice would be greatly appreciated.

Oct 03 12:01 PM

[Hustle617:]

Mhtx heating up.... closed at .17

Nov 19 04:51 PM